Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics Statistics

Total Valuation

VVOS has a market cap or net worth of $15.14 million. The enterprise value is $10.39 million.

Market Cap	15.14M
Enterprise Value	10.39M

Important Dates

The last earnings date was Monday, March 31, 2025, after market close.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

VVOS has 5.89 million shares outstanding. The number of shares has increased by 311.68% in one year.

Current Share Class	5.89M
Shares Outstanding	5.89M
Shares Change (YoY)	+311.68%
Shares Change (QoQ)	+9.34%
Owned by Insiders (%)	1.24%
Owned by Institutions (%)	16.17%
Float	5.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.86
Forward PS	0.85
PB Ratio	1.90
P/TBV Ratio	3.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.19.

Current Ratio	1.50
Quick Ratio	1.34
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -266.25% and return on invested capital (ROIC) is -117.62%.

Return on Equity (ROE)	-266.25%
Return on Assets (ROA)	-53.68%
Return on Invested Capital (ROIC)	-117.62%
Return on Capital Employed (ROCE)	-108.39%
Revenue Per Employee	$122,203
Profits Per Employee	-$90,537
Employee Count	123
Asset Turnover	1.16
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.08% in the last 52 weeks. The beta is 7.28, so VVOS's price volatility has been higher than the market average.

Beta (5Y)	7.28
52-Week Price Change	-24.08%
50-Day Moving Average	3.59
200-Day Moving Average	3.22
Relative Strength Index (RSI)	30.17
Average Volume (20 Days)	78,482

Short Selling Information

The latest short interest is 249,020, so 4.23% of the outstanding shares have been sold short.

Short Interest	249,020
Short Previous Month	344,021
Short % of Shares Out	4.23%
Short % of Float	4.48%
Short Ratio (days to cover)	1.42

Income Statement

In the last 12 months, VVOS had revenue of $15.03 million and -$11.14 million in losses. Loss per share was -$2.22.

Revenue	15.03M
Gross Profit	9.02M
Operating Income	-11.17M
Pretax Income	-15.64M
Net Income	-11.14M
EBITDA	-10.59M
EBIT	-11.17M
Loss Per Share	-$2.22

Balance Sheet

The company has $6.26 million in cash and $1.51 million in debt, giving a net cash position of $4.75 million or $0.81 per share.

Cash & Cash Equivalents	6.26M
Total Debt	1.51M
Net Cash	4.75M
Net Cash Per Share	$0.81
Equity (Book Value)	7.95M
Book Value Per Share	1.35
Working Capital	2.50M

Cash Flow

In the last 12 months, operating cash flow was -$12.69 million and capital expenditures -$568,000, giving a free cash flow of -$13.26 million.

Operating Cash Flow	-12.69M
Capital Expenditures	-568,000
Free Cash Flow	-13.26M
FCF Per Share	-$2.25

Margins

Gross margin is 60.00%, with operating and profit margins of -74.32% and -74.09%.

Gross Margin	60.00%
Operating Margin	-74.32%
Pretax Margin	-74.09%
Profit Margin	-74.09%
EBITDA Margin	-70.45%
EBIT Margin	-74.32%
FCF Margin	n/a

Dividends & Yields

VVOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-311.68%
Shareholder Yield	-311.68%
Earnings Yield	-73.57%
FCF Yield	-87.60%

Analyst Forecast

The average price target for VVOS is $6.30, which is 145.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.30
Price Target Difference	145.14%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 27, 2023. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Oct 27, 2023
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1